A citation-based method for searching scientific literature

Evgeny N Mikhaylov, Tamara A Lyubimtseva, Aleksandr D Vakhrushev, Dmitry Stepanov, Dmitry S Lebedev, Elena Yu Vasilieva, Alexandra O Konradi, Evgeny V Shlyakhto. Interdiscip Perspect Infect Dis 2022
Times Cited: 3







List of co-cited articles
49 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
100

Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial.
Khalil Ansarin, Ramin Tolouian, Mohammadreza Ardalan, Ali Taghizadieh, Mojtaba Varshochi, Soheil Teimouri, Tahere Vaezi, Hamed Valizadeh, Parviz Saleh, Saeid Safiri,[...]. Bioimpacts 2020
46
100

Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID-19: An Open-Label Randomized Controlled Pilot Study.
Ting Li, Laifang Sun, Wenwu Zhang, Chanfan Zheng, Chenchen Jiang, Mingjing Chen, Di Chen, Zhijuan Dai, Shihui Bao, Xian Shen. Clin Transl Sci 2020
16
100

Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response.
Ilona Glowacka, Stephanie Bertram, Marcel A Müller, Paul Allen, Elizabeth Soilleux, Susanne Pfefferle, Imke Steffen, Theodros Solomon Tsegaye, Yuxian He, Kerstin Gnirss,[...]. J Virol 2011
610
100

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry.
Graham Simmons, Dhaval N Gosalia, Andrew J Rennekamp, Jacqueline D Reeves, Scott L Diamond, Paul Bates. Proc Natl Acad Sci U S A 2005
658
66

Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.
Shutoku Matsuyama, Noriyo Nagata, Kazuya Shirato, Miyuki Kawase, Makoto Takeda, Fumihiro Taguchi. J Virol 2010
456
66

The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis.
Jared M Lucas, Cynthia Heinlein, Tom Kim, Susana A Hernandez, Muzdah S Malik, Lawrence D True, Colm Morrissey, Eva Corey, Bruce Montgomery, Elahe Mostaghel,[...]. Cancer Discov 2014
248
66

A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry.
Ana Shulla, Taylor Heald-Sargent, Gitanjali Subramanya, Jincun Zhao, Stanley Perlman, Tom Gallagher. J Virol 2011
408
66

Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.
Jesper D Gunst, Nina B Staerke, Marie H Pahus, Lena H Kristensen, Jacob Bodilsen, Nicolai Lohse, Lars S Dalgaard, Dorthe Brønnum, Ole Fröbert, Bo Hønge,[...]. EClinicalMedicine 2021
56
66


Influenza virus activating host proteases: Identification, localization and inhibitors as potential therapeutics.
Wolfgang Garten, Carolin Braden, Annika Arendt, Catharina Peitsch, Joanna Baron, Yinghui Lu, Kerstin Pawletko, Kornelia Hardes, Torsten Steinmetzer, Eva Böttcher-Friebertshäuser. Eur J Cell Biol 2015
53
66

Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues.
M H Vaarala, K S Porvari, S Kellokumpu, A P Kyllönen, P T Vihko. J Pathol 2001
108
66


The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets.
Thomas P Peacock, Daniel H Goldhill, Jie Zhou, Laury Baillon, Rebecca Frise, Olivia C Swann, Ruthiran Kugathasan, Rebecca Penn, Jonathan C Brown, Raul Y Sanchez-David,[...]. Nat Microbiol 2021
164
66

Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts.
Stephanie Bertram, Adeline Heurich, Hayley Lavender, Stefanie Gierer, Simon Danisch, Paula Perin, Jared M Lucas, Peter S Nelson, Stefan Pöhlmann, Elizabeth J Soilleux. PLoS One 2012
274
66

TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells.
Dorothea Bestle, Miriam Ruth Heindl, Hannah Limburg, Thuy Van Lam van, Oliver Pilgram, Hong Moulton, David A Stein, Kornelia Hardes, Markus Eickmann, Olga Dolnik,[...]. Life Sci Alliance 2020
309
66

Coronavirus biology and replication: implications for SARS-CoV-2.
Philip V'kovski, Annika Kratzel, Silvio Steiner, Hanspeter Stalder, Volker Thiel. Nat Rev Microbiol 2021
759
66

SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells.
Soeren Lukassen, Robert Lorenz Chua, Timo Trefzer, Nicolas C Kahn, Marc A Schneider, Thomas Muley, Hauke Winter, Michael Meister, Carmen Veith, Agnes W Boots,[...]. EMBO J 2020
557
66

The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade.
B Coutard, C Valle, X de Lamballerie, B Canard, N G Seidah, E Decroly. Antiviral Res 2020
878
66

Inhibition of TMPRSS2 by HAI-2 reduces prostate cancer cell invasion and metastasis.
Chun-Jung Ko, Ting-Wei Hsu, Shang-Ru Wu, Shao-Wei Lan, Ting-Feng Hsiao, Hsin-Ying Lin, Hsin-Hsien Lin, Hsin-Fang Tu, Cheng-Fan Lee, Cheng-Chung Huang,[...]. Oncogene 2020
17
66

The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells.
Mutsuo Yamaya, Yoshitaka Shimotai, Yukimasa Hatachi, Nadine Lusamba Kalonji, Yukiko Tando, Yasuo Kitajima, Kaori Matsuo, Hiroshi Kubo, Ryoichi Nagatomi, Seiji Hongo,[...]. Pulm Pharmacol Ther 2015
53
66


SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells.
I-Chueh Huang, Berend Jan Bosch, Fang Li, Wenhui Li, Kyoung Hoa Lee, Sorina Ghiran, Natalya Vasilieva, Terence S Dermody, Stephen C Harrison, Philip R Dormitzer,[...]. J Biol Chem 2006
235
66

Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19.
Xin Hu, Jonathan H Shrimp, Hui Guo, Miao Xu, Catherine Z Chen, Wei Zhu, Alexey V Zakharov, Sankalp Jain, Paul Shinn, Anton Simeonov,[...]. ACS Pharmacol Transl Sci 2021
14
66

Alpha-1 Antitrypsin for COVID-19 Treatment: Dual Role in Antiviral Infection and Anti-Inflammation.
Chengliang Yang, Shaf Keshavjee, Mingyao Liu. Front Pharmacol 2020
18
66

Cell entry mechanisms of SARS-CoV-2.
Jian Shang, Yushun Wan, Chuming Luo, Gang Ye, Qibin Geng, Ashley Auerbach, Fang Li. Proc Natl Acad Sci U S A 2020
66

The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Kun Li, David K Meyerholz, Jennifer A Bartlett, Paul B McCray. mBio 2021
24
66

Oral trypsin inhibitor can improve reflux esophagitis after distal gastrectomy concomitant with decreased trypsin activity.
Koji Kono, Akihiro Takahashi, Hidemitsu Sugai, Toshiyoshi Umekawa, Tomoko Yano, Komei Kamiyasu, Makoto Teramatsu, Hideki Fujii. Am J Surg 2005
18
66

Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19.
Markus Hoffmann, Simon Schroeder, Hannah Kleine-Weber, Marcel A Müller, Christian Drosten, Stefan Pöhlmann. Antimicrob Agents Chemother 2020
263
66



Regulation of the epithelial sodium channel by serine proteases in human airways.
Scott H Donaldson, Andrew Hirsh, Dong Chen Li, Ginger Holloway, Julie Chao, Richard C Boucher, Sherif E Gabriel. J Biol Chem 2002
197
66



Effect of bromhexine in hospitalized patients with COVID-19.
Ramin Tolouian, Zuber D Mulla, Hamidreza Jamaati, Abdolreza Babamahmoodi, Majid Marjani, Raha Eskandari, Farzaneh Dastan. J Investig Med 2021
4
66

Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2.
Nurit P Azouz, Andrea M Klingler, Victoria Callahan, Ivan V Akhrymuk, Katarina Elez, Lluís Raich, Brandon M Henry, Justin L Benoit, Stefanie W Benoit, Frank Noé,[...]. Pathog Immun 2021
32
66


TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells.
Ya-Wen Chen, Ming-Shyue Lee, Amanda Lucht, Feng-Pai Chou, Wei Huang, Thomas C Havighurst, KyungMann Kim, Jehng-Kang Wang, Toni M Antalis, Michael D Johnson,[...]. Am J Pathol 2010
95
66

The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema.
Alessandro N Franciosi, Cormac McCarthy, Noel Gerry McElvaney. Expert Rev Respir Med 2015
10
66

Molecular mechanism of inhibiting the SARS-CoV-2 cell entry facilitator TMPRSS2 with camostat and nafamostat.
Tim Hempel, Lluís Raich, Simon Olsson, Nurit P Azouz, Andrea M Klingler, Markus Hoffmann, Stefan Pöhlmann, Marc E Rothenberg, Frank Noé. Chem Sci 2020
18
66

Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites.
Sandrine Belouzard, Victor C Chu, Gary R Whittaker. Proc Natl Acad Sci U S A 2009
574
66

Androgen receptor and androgen-dependent gene expression in lung.
Laura Mikkonen, Päivi Pihlajamaa, Biswajyoti Sahu, Fu-Ping Zhang, Olli A Jänne. Mol Cell Endocrinol 2010
153
66

Structure-based phylogeny identifies avoralstat as a TMPRSS2 inhibitor that prevents SARS-CoV-2 infection in mice.
Young Joo Sun, Gabriel Velez, Dylan E Parsons, Kun Li, Miguel E Ortiz, Shaunik Sharma, Paul B McCray, Alexander G Bassuk, Vinit B Mahajan. J Clin Invest 2021
11
66

Characterization of the Inflammatory Response to Severe COVID-19 Illness.
Oliver J McElvaney, Natalie L McEvoy, Oisín F McElvaney, Tomás P Carroll, Mark P Murphy, Danielle M Dunlea, Orna Ní Choileáin, Jennifer Clarke, Eoin O'Connor, Grace Hogan,[...]. Am J Respir Crit Care Med 2020
250
66

Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation.
Daniela Meyer, Frank Sielaff, Maya Hammami, Eva Böttcher-Friebertshäuser, Wolfgang Garten, Torsten Steinmetzer. Biochem J 2013
80
66

Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide.
Fei Li, Ming Han, Pengfei Dai, Wei Xu, Juan He, Xiaoting Tao, Yang Wu, Xinyuan Tong, Xinyi Xia, Wangxin Guo,[...]. Nat Commun 2021
31
66

Nafamostat in hospitalized patients with moderate to severe COVID-19 pneumonia: a randomised Phase II clinical trial.
Sergey V Zhuravel, Oleg K Khmelnitskiy, Oleg O Burlaka, Alexey I Gritsan, Boris M Goloshchekin, Seieun Kim, Ka Young Hong. EClinicalMedicine 2021
9
66

Camostat Mesylate May Reduce Severity of Coronavirus Disease 2019 Sepsis: A First Observation.
Heike Hofmann-Winkler, Onnen Moerer, Sabine Alt-Epping, Anselm Bräuer, Benedikt Büttner, Martin Müller, Torben Fricke, Julian Grundmann, Lars-Olav Harnisch, Daniel Heise,[...]. Crit Care Explor 2020
26
66

TMPRSS2 Is the Major Activating Protease of Influenza A Virus in Primary Human Airway Cells and Influenza B Virus in Human Type II Pneumocytes.
Hannah Limburg, Anne Harbig, Dorothea Bestle, David A Stein, Hong M Moulton, Julia Jaeger, Harshavardhan Janga, Kornelia Hardes, Janine Koepke, Leon Schulte,[...]. J Virol 2019
58
66

Severe Covid-19.
David A Berlin, Roy M Gulick, Fernando J Martinez. N Engl J Med 2020
604
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.